Metropolitan Life Insurance Company (MetLife)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,365
| Closed | -$5.65K | – | 420 |
|
2024
Q1 | $5.65K | Sell |
2,365
-414
| -15% | -$989 | ﹤0.01% | 2241 |
|
2023
Q4 | $9.25K | Sell |
2,779
-3,085
| -53% | -$10.3K | ﹤0.01% | 2203 |
|
2023
Q3 | $21.9K | Buy |
5,864
+1,811
| +45% | +$6.77K | ﹤0.01% | 1850 |
|
2023
Q2 | $17.3K | Buy |
+4,053
| New | +$17.3K | ﹤0.01% | 2008 |
|
2023
Q1 | – | Sell |
-4,249
| Closed | -$33.7K | – | 2336 |
|
2022
Q4 | $33.7K | Hold |
4,249
| – | – | ﹤0.01% | 1721 |
|
2022
Q3 | $40.8K | Hold |
4,249
| – | – | ﹤0.01% | 1596 |
|
2022
Q2 | $30.8K | Hold |
4,249
| – | – | ﹤0.01% | 1802 |
|
2022
Q1 | $54.9K | Sell |
4,249
-13,564
| -76% | -$175K | ﹤0.01% | 1543 |
|
2021
Q4 | $284K | Hold |
17,813
| – | – | ﹤0.01% | 1770 |
|
2021
Q3 | $286K | Buy |
+17,813
| New | +$286K | ﹤0.01% | 1814 |
|
2021
Q2 | – | Sell |
-15,893
| Closed | -$232K | – | 2737 |
|
2021
Q1 | $232K | Sell |
15,893
-1,896
| -11% | -$27.7K | ﹤0.01% | 1917 |
|
2020
Q4 | $309K | Hold |
17,789
| – | – | ﹤0.01% | 1664 |
|
2020
Q3 | $326K | Sell |
17,789
-2,505
| -12% | -$45.9K | 0.01% | 1491 |
|
2020
Q2 | $362K | Hold |
20,294
| – | – | 0.01% | 1436 |
|
2020
Q1 | $329K | Buy |
20,294
+343
| +2% | +$5.56K | 0.01% | 1306 |
|
2019
Q4 | $359K | Sell |
19,951
-794
| -4% | -$14.3K | 0.01% | 1532 |
|
2019
Q3 | $420K | Buy |
20,745
+3,674
| +22% | +$74.4K | 0.01% | 1403 |
|
2019
Q2 | $377K | Hold |
17,071
| – | – | 0.01% | 1485 |
|
2019
Q1 | $233K | Hold |
17,071
| – | – | ﹤0.01% | 1798 |
|
2018
Q4 | $154K | Buy |
17,071
+1,200
| +8% | +$10.9K | ﹤0.01% | 1982 |
|
2018
Q3 | $262K | Buy |
+15,871
| New | +$262K | ﹤0.01% | 1826 |
|
2015
Q4 | – | Sell |
-16,813
| Closed | -$337K | – | 2589 |
|
2015
Q3 | $337K | Buy |
+16,813
| New | +$337K | ﹤0.01% | 1904 |
|